Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging

Radiotherapy and Oncology

Volumn 98, Issue 3, 2011, Pages 360-364

  Gulliksrud, Kristine ^a   Øvrebø, Kirsti Marie ^a   Mathiesen, Berit ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dynamic contrast enhanced MRI; Hypoxia; Melanoma xenografts

Indexed keywords

GADOLINIUM PENTETATE; PIMONIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FEMALE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIVITY; TUMOR DIFFERENTIATION; TUMOR MODEL; TUMOR RESISTANCE;

ANIMALS; ANOXIA; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952438916     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.12.016     Document Type: Article

References (36)

1. M. Höckel, and P. Vaupel Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects J Natl Cancer Inst 93 2001 266 276 (Pubitemid 32219813)
2. B.G. Wouters, S.A. Weppler, and M. Koritzinsky Hypoxia as a target for combined modality treatments Eur J Cancer 38 2002 240 257 (Pubitemid 34136999)
3. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 2007 225 239 (Pubitemid 47101660)
4. J.L. Tatum, G.J. Kelloff, and R.J. Gillies Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy Int J Radiat Biol 82 2006 699 757 (Pubitemid 44832019)
5. E.G.C. Troost, D.A.X. Schinagl, J. Bussink, W.J.G. Oyen, and J.H.A.M. Kaanders Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours Radiother Oncol 96 2010 328 334
6. D. Thorwarth, and M. Alber Implementation of hypoxia imaging into treatment planning and delivery Radiother Oncol 97 2010 172 175
7. Z. Wang, M.Y. Su, and O. Nalcioglu Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension Technol Cancer Res Treat 1 2002 29 38 (Pubitemid 36553952)
8. R.A. Cooper, B.M. Carrington, and J.A. Loncaster Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix Radiother Oncol 57 2000 53 59
9. I.C. Benjaminsen, B.A. Graff, K.G. Brurberg, and E.K. Rofstad Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts Magn Reson Med 52 2004 269 276 (Pubitemid 39025270)
10. I.C. Benjaminsen, K.G. Brurberg, E.B. Ruud, and E.K. Rofstad Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling Magn Reson Imaging 26 2008 160 170
11. T.A.M. Egeland, J.V. Gaustad, I.K. Vestvik, I.C. Benjaminsen, B. Mathiesen, and E.K. Rofstad Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI Magn Reson Med 55 2006 874 882
12. I.K. Vestvik, T.A.M. Egeland, J.V. Gaustad, B. Mathiesen, and E.K. Rofstad Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI J Magn Reson Imaging 26 2007 1033 1042 (Pubitemid 47548165)
13. T.A.M. Egeland, T.G. Simonsen, J.V. Gaustad, K. Gulliksrud, C. Ellingsen, and E.K. Rofstad Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images Radiat Res 172 2009 339 347
14. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232 (Pubitemid 29463104)
15. K. Gulliksrud, B. Mathiesen, K. Galappathi, and E.K. Rofstad Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors Radiother Oncol 97 2010 233 238
16. H.J. Bernsen, P.F. Rijken, N.E. Hagemeier, and A.J. van der Kogel A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites Microvasc Res 57 1999 244 257 (Pubitemid 29393270)
17. C.M. Zechmann, E.C. Woenne, and G. Brix Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors Neoplasia 9 2007 57 67 (Pubitemid 46203934)
18. E.K. Rofstad Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern Br J Cancer 70 1994 804 812 (Pubitemid 24331069)
19. E.K. Rofstad, K. Galappathi, B. Mathiesen, and E.B.M. Ruud Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis Clin Cancer Res 13 2007 1971 1978 (Pubitemid 46649862)
20. E.K. Rofstad Hypoxia and reoxygenation in human melanoma xenografts Int J Radiat Oncol Biol Phys 17 1989 81 89 (Pubitemid 19173242)
21. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof, and J. Kramer Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI Magn Reson Med 31 1994 567 571 (Pubitemid 24129954)
22. E.K. Rofstad, and K. Mseide Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours Int J Radiat Biol 75 1999 1377 1393
23. E.K. Rofstad, J.V. Gaustad, K.G. Brurberg, B. Mathiesen, K. Galappathi, and T.G. Simonsen Radiocurability is associated with interstitial fluid pressure in human tumor xenografts Neoplasia 11 2009 1243 1251
24. E.K. Rofstad, E.B.M. Ruud, B. Mathiesen, and K. Galappathi Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue Clin Cancer Res 16 2010 936 945
25. J.E. Moulder, and S. Rockwell Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data Int J Radiat Oncol Biol Phys 10 1984 695 712 (Pubitemid 14084223)
26. C.J. Gulledge, and M.W. Dewhirst Tumor oxygenation: a matter of supply and demand Anticancer Res 16 1996 741 750 (Pubitemid 126501652)
27. R.J. Gillies, P.A. Schornack, T.W. Secomb, and N. Raghunand Causes and effects of heterogeneous perfusion in tumors Neoplasia 1 1999 197 207
28. E.K. Rofstad, and E.F. Halsør Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts Cancer Res 60 2000 4932 4938
29. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 1989 6449 6465 (Pubitemid 20008770)
30. P. Vaupel Tumor microenvironmental physiology and its implications for radiation oncology Semin Radiat Oncol 14 2004 198 206 (Pubitemid 38903223)
31. M. Nordsmark, J.G. Eriksen, V. Gebski, J. Alsner, M.R. Horsman, and J. Overgaard Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients Radiother Oncol 83 2007 389 397 (Pubitemid 46907981)
32. D. Zhao, A. Constantinescu, C.H. Chang, E.W. Hahn, and R.P. Mason Correlation of tumor oxygen dynamics with radiation response of the Dunning prostate R3327-HI tumor Radiat Res 159 2003 621 631 (Pubitemid 36539241)
33. V.A. Bourke, D. Zhao, and J. Gilio Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor Int J Radiat Oncol Biol Phys 67 2007 1179 1186
34. K. Gulliksrud, K.G. Brurberg, and E.K. Rofstad Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure Radiother Oncol 91 2009 107 113
35. K.G. Brurberg, I.C. Benjaminsen, L.M.R. Dørum, and E.K. Rofstad Fluctuations in tumor blood perfusion assessed by dynamic-contrast enhanced MRI Magn Reson Med 58 2007 473 481 (Pubitemid 350154957)
36. M.A. Zahra, K.G. Hollingsworth, E. Sala, D.J. Lomas, and L.T. Tan Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy Lancet Oncol 8 2007 63 74 (Pubitemid 44943092)